Canada Testing, Screening and Monitoring (TSM) Devices Market Overview, 2028

The Canada Testing, Screening, and Monitoring (TSM) market is anticipated to grow at more than 8.50% CAGR from 2023 to 2028.

Canada has been experiencing a gradual increase in healthcare expenditure, driven by factors such as an aging population, the prevalence of chronic diseases, and advancements in medical technologies. This increased investment supports the adoption of advanced TSM devices in the healthcare system. The rising incidence of chronic diseases, including diabetes, cardiovascular diseases, and respiratory conditions, has led to an increased demand for monitoring and screening devices. TSM devices play a crucial role in the early detection, management, and monitoring of these chronic conditions. On-going technological advancements in TSM devices contribute to their increased adoption. Innovations such as point-of-care testing, wearable devices, and connected health solutions enhance the efficiency and accuracy of testing and monitoring processes. Government initiatives and healthcare policies in Canada often focus on improving healthcare infrastructure and patient outcomes. Supportive policies and funding for healthcare technology adoption create an environment conducive to the growth of the TSM Devices market. Increasing awareness among the Canadian population about the importance of preventive healthcare and regular health check-ups has driven the demand for screening and monitoring devices. People are becoming more proactive in managing their health, contributing to market growth. Canada has an aging population, and the elderly are more prone to chronic diseases and conditions that require continuous monitoring. TSM devices, including those designed for home use, become crucial in managing the health of an aging demographic. There is a growing emphasis on preventive medicine and early disease detection in Canada. TSM devices, particularly those facilitating regular health screenings and monitoring, align with this healthcare approach, contributing to market growth. Instances of infectious diseases, such as flu outbreaks and the COVID-19 pandemic, highlight the need for rapid and widespread testing. This has led to increased investment in testing infrastructure and technologies in Canada. According to the research report "Canada Testing, Screening, and Monitoring (TSM) Market Overview, 2028," published by Bonafide Research, the Canada Testing, Screening, and Monitoring (TSM) market is anticipated to grow at more than 8.50% CAGR from 2023 to 2028. Telehealth services, including virtual consultations and remote monitoring, have experienced significant growth in Canada. This trend has propelled the demand for TSM devices that support telehealth initiatives, allowing patients to monitor their health from home. Wearable devices equipped with health monitoring features have gained popularity in Canada. Advanced wearables can track various health metrics, such as heart rate, physical activity, and sleep patterns, contributing to a more holistic approach to health monitoring. The integration of digital health solutions into the Canadian healthcare system is advancing. TSM devices are part of connected health ecosystems, allowing for the seamless exchange of patient data between devices and healthcare providers. The application of artificial intelligence (AI) and machine learning in diagnostic processes is on the rise. TSM devices are incorporating these technologies to improve the accuracy and efficiency of diagnostic procedures. The regulatory environment, including adherence to standards set by Health Canada, continues to play a crucial role in shaping the TSM devices market. A clear regulatory pathway ensures the safety and effectiveness of these devices. AR and VR technologies are finding applications in medical training, patient education, and even certain diagnostic procedures. The integration of these technologies into TSM devices enhances the overall healthcare experience. The concept of smart home health monitoring involves the integration of various TSM devices into a unified system. This system allows individuals to monitor multiple health parameters seamlessly within their home environment.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

In terms of product the market is categorized into Blood Glucose Monitor, Heart Rate Monitors, Multi Parameter Patient Monitoring Device, Drug Alcohol Screening Testing, ECG Devices and others. A rise in drug abuse and substance use within Canada can drive the demand for drug screening devices. Employers, law enforcement agencies, and healthcare providers may invest in advanced drug screening technologies to address public health concerns related to drug abuse. The implementation of workplace drug testing programs, driven by regulatory requirements and concerns about workplace safety, can contribute to the growth of the Drug Screening segment. Industries such as transportation, construction, and healthcare may have stringent drug testing policies. Employers may increasingly implement pre-employment and random drug testing to ensure a drug-free workplace environment. This trend can contribute to the demand for efficient and reliable drug screening devices. An increase in the number of drug rehabilitation programs and initiatives may lead to a higher demand for drug screening devices. Regular monitoring of individuals undergoing rehabilitation can be essential for treatment efficacy. Furthermore the market is categorized into Cardiovascular Disorders & Hypertension, Diabetes, Pregnancy, Respiratory Diseases, Cancer, Movement Disorders, Hearing Disorders, Wound Care and Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV) based on indication. Cardiovascular disorders, including conditions such as heart disease and stroke, are prevalent in Canada. The aging population and lifestyle factors contribute to the high incidence of cardiovascular diseases, driving the demand for testing, screening, and monitoring devices. Hypertension (high blood pressure) is a common cardiovascular risk factor. The rising incidence of hypertension in Canada contributes to the need for continuous monitoring and management, leading to increased adoption of TSM devices. Holistic patient care models that address not only acute conditions but also chronic diseases, including cardiovascular disorders, may involve continuous monitoring. Integrated care approaches contribute to the demand for TSM devices. The market is bifurcated into Hospitals, Home and others based on end user. Home monitoring is particularly crucial for individuals managing chronic conditions. Testing and monitoring devices for conditions like diabetes, hypertension, and cardiovascular diseases allow patients to actively participate in their care from the comfort of their homes. Home testing and monitoring devices offer the convenience of conducting tests and measurements in a comfortable and familiar environment. Patients are more likely to adhere to regular monitoring routines when it can be done without the need for frequent clinic visits. The design of home testing devices emphasizes user-friendliness and accessibility. Intuitive interfaces, clear instructions, and devices that do not require specialized training contribute to their widespread adoption among consumers. Increased awareness of the availability and benefits of home-based testing and monitoring solutions drives consumer interest. Educational campaigns and healthcare initiatives promote the use of these devices for routine health management. Home monitoring can contribute to cost savings for both individuals and healthcare systems. Avoiding unnecessary clinic visits and hospital stays can reduce overall healthcare expenditures. Home monitoring devices that seamlessly integrate with digital health platforms, mobile apps, and electronic health records enhance the overall user experience. Interconnected systems support better communication between patients and healthcare providers. Considered in this report: • Geography: Canada • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Aspects covered in this report: • Canada Testing, Screening and Monitoring market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Product: • Blood Glucose Monitor • Heart Rate Monitors • Multiparameter Patient Monitoring • Drug Screening • Electrocardiograph (ECG) • Others (Blood Pressure Monitoring Devices, Pulse Oximeter, Patient Temperature Monitoring, Fetal Monitoring Devices, Others) By End User: • Hospitals • Home • Others

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

By Indication: • Cardiovascular Disorders & Hypertension • Diabetes • Pregnancy • Respiratory Diseases • Cancer • Movement Disorders • Hearing Disorders • Wound Care • Other Indications The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources. Intended audience: This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Testing, Screening and Monitoring industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

Table of Contents

  • Table of Contents
  • 1. Executive Summary
  • 2. Market Structure
  • 2.1. Market Considerate
  • 2.2. Assumptions
  • 2.3. Limitations
  • 2.4. Abbreviations
  • 2.5. Sources
  • 2.6. Definitions
  • 2.7. Geography
  • 3. Research Methodology
  • 3.1. Secondary Research
  • 3.2. Primary Data Collection
  • 3.3. Market Formation & Validation
  • 3.4. Report Writing, Quality Check & Delivery
  • 4. Canada Macro Economic Indicators
  • 5. Market Dynamics
  • 5.1. Key Findings
  • 5.2. Key Developments - 2021
  • 5.3. Market Drivers & Opportunities
  • 5.4. Market Restraints & Challenges
  • 5.5. Market Trends
  • 5.6. Covid-19 Effect
  • 5.7. Supply chain Analysis
  • 5.8. Policy & Regulatory Framework
  • 5.9. Industry Experts Views
  • 6. Canada Testing, Screening, and Monitoring (TSM) Devices Market Overview
  • 6.1. Market Size By Value
  • 6.2. Market Size and Forecast By Products
  • 6.3. Market Size and Forecast By End User
  • 6.4. Market Size and Forecast By Indication
  • 7. Canada Testing, Screening, and Monitoring (TSM) Devices Market Segmentations
  • 7.1. Canada Testing, Screening, and Monitoring (TSM) Devices Market, By Products
  • 7.1.1. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Blood Glucose Monitor, 2017-2028
  • 7.1.2. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Heart Rate Monitors, 2017-2028
  • 7.1.3. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Multiparameter Patient Monitoring, 2017-2028
  • 7.1.4. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Drug Screening, 2017-2028
  • 7.1.5. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Electrocardiograph (ECG), 2017-2028
  • 7.1.6. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Others, 2017-2028
  • 7.2. Canada Testing, Screening, and Monitoring (TSM) Devices Market, By End User
  • 7.2.1. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Hospitals, 2017-2028
  • 7.2.2. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Home, 2017-2028
  • 7.2.3. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Others, 2017-2028
  • 7.3. Canada Testing, Screening, and Monitoring (TSM) Devices Market, By Indication
  • 7.3.1. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Cardiovascular Disorders & Hypertension, 2017-2028
  • 7.3.2. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Diabetes, 2017-2028
  • 7.3.3. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Pregnancy, 2017-2028
  • 7.3.4. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Respiratory Diseases, 2017-2028
  • 7.3.5. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Cancer, 2017-2028
  • 7.3.6. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Movement Disorders, 2017-2028
  • 7.3.7. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Wound Care, 2017-2028
  • 7.3.8. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Other Indications, 2017-2028
  • 8. Canada Testing, Screening, and Monitoring (TSM) Devices Market Opportunity Assessment
  • 8.1. By Products, 2023 to 2028
  • 8.2. By End User, 2023 to 2028
  • 8.3. By Indication, 2023 to 2028
  • 9. Competitive Landscape
  • 9.1. Porter's Five Forces
  • 9.2. Company Profile
  • 9.2.1. Company 1
  • 9.2.2. Company 2
  • 9.2.3. Company 3
  • 9.2.4. Company 4
  • 9.2.5. Company 5
  • 9.2.6. Company 6
  • 9.2.7. Company 7
  • 9.2.8. Company 8
  • 10. Strategic Recommendations
  • 11. Disclaimer

List of Table
Table 1: Influencing Factors for Global Testing, Screening, and Monitoring (TSM) Devices Market, 2022
Table 2: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size and Forecast By Products (2017, 2022 & 2028F)
Table 3: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size and Forecast By End User (2017, 2022 & 2028F)
Table 4: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size and Forecast By Indication (2017, 2022 & 2028F)
Table 5: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Blood Glucose Monitor (2017 to 2028) in USD Million
Table 6: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Heart Rate Monitors (2017 to 2028) in USD Million
Table 7: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Multiparameter Patient Monitoring (2017 to 2028) in USD Million
Table 8: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Drug Screening (2017 to 2028) in USD Million
Table 9: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Electrocardiograph (ECG) (2017 to 2028) in USD Million
Table 10: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Others (2017 to 2028) in USD Million
Table 11: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Hospitals (2017 to 2028) in USD Million
Table 12: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Home (2017 to 2028) in USD Million
Table 13: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Others (2017 to 2028) in USD Million
Table 14: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Cardiovascular Disorders & Hypertension (2017 to 2028) in USD Million
Table 15: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Diabetes (2017 to 2028) in USD Million
Table 16: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Pregnancy (2017 to 2028) in USD Million
Table 17: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Respiratory Diseases (2017 to 2028) in USD Million
Table 18: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Cancer (2017 to 2028) in USD Million
Table 19: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Movement Disorders (2017 to 2028) in USD Million
Table 20: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Wound Care (2017 to 2028) in USD Million
Table 21: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Other Indications (2017 to 2028) in USD Million

List of Figures
Figure 1: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 2: Market Attractiveness Index, By Products
Figure 3: Market Attractiveness Index, By End User
Figure 4: Market Attractiveness Index, By Indication
Figure 5: Porter's Five Forces of Canada Testing, Screening, and Monitoring (TSM) Devices Market
Logo

Canada Testing, Screening and Monitoring (TSM) Devices Market Overview, 2028

Contact usWe are friendly and approachable, give us a call.